Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling

Non-alcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. The gut-liver axis is a potential therapy for NASH. Sodium cholate (SC) is a choleretic drug whose main component is bile acids and has anti-inflammatory, antifibrotic, and hepatoprotec...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Linyu, Yu, Ze, Liang, Xiaolin, Yao, Jiyou, Fu, Yanfang, He, Xu, Ren, Xiaoling, Chen, Jiajia, Li, Xuejuan, Lu, Minqiang, Lan, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988322/
https://www.ncbi.nlm.nih.gov/pubmed/36706173
http://dx.doi.org/10.1097/HC9.0000000000000039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988322/
https://www.ncbi.nlm.nih.gov/pubmed/36706173
http://dx.doi.org/10.1097/HC9.0000000000000039

Ejemplares similares